|
Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril)
|
|
|
Desosaminylazithromycin (15 mg) ((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-dimethylamino-Beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one)
|
|
|
N-Demethylazithromycin (15 mg)
|
|
|
D-camphor sulfonic acid (100 mg)
|
|
|
Dacarbazine (125 mg)
|
|
|
Dacarbazine Related Compound A (50 mg) (5-aminoimidazole-4-carboxamide hydrochloride)
|
|
|
Dacarbazine Related Compound B (50 mg) (2-Azahypoxanthine monohydrate)
|
|
|
Dactinomycin (50 mg)
|
|
|
Daidzein (25 mg)
|
|
|
Daidzin (30 mg)
|
|
|
Dalfampridine (200 mg)
|
|
|
Dalteparin Sodium (300 mg)
|
|
|
Danazol (200 mg)
|
|
|
Dalfampridine Related Compound A (25 mg) (4-Aminopyridine 1-oxide)
|
|
|
Dalfampridine Related Compound B (50 mg) (3,5-Dibromopyridin-4-amine)
|
|
|
Dalfampridine Related Compound C (25 mg) (1,3-Di(pyridin-4-yl)urea)
|
|
|
α-ダマスコン
販売終了
|
|
|
δ-ダマスコン
販売終了
|
|
|
β-ダマスコン
販売終了
|
|
|
Dantrolene (200 mg)
|
|
|
Dantrolene Sodium (100 mg)
|
|
|
Dantrolene Related Compound A (50 mg) (1,2-Bis{[5-(4-nitrophenyl)furan-2-yl]methylene}hydrazine)
|
|
|
Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone)
|
|
|
Dantrolene Related Compound C (50 mg) (5-(4-Nitrophenyl)furan-2-carbaldehyde)
|
|
|
Dapsone (200 mg)
|
|
|
Darifenacin Hydrobromide (150 mg)
|
|
|
Darifenacin Chiral Peak ID Mixture (25 mg) (See USP Certificate for full Chemical Name)
|
|
|
Darifenacin Peak ID Mixture (25 mg) (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%))
|
|
|
Daunorubicinone (25 mg) ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione)
|
|
|
Daunorubicin Hydrochloride (200 mg)
|
|
|
Decoquinate (200 mg)
|
|
|
Deferasirox System Suitability Mixture (20 mg) (A mixture containing Deferasirox, Benzoxazinone analog, Deferasirox ethyl ester, Deferasirox 1,2-isomer, Deferasirox 1,3-isomer and Salicylimide)
|
|
|
Deferoxamine Mesylate (300 mg)
|
|
|
Deflazacort (100 mg)
|
|
|
Dehydroacetic Acid (200 mg)
|
|
|
Dehydrocarteolol Hydrochloride (100 mg) (5-[3-(tert-Butylamino)-2-hydroxypropoxy]quinolin-2(1H)-one hydrochloride)
|
|
|
Dehydrocholic Acid (200 mg)
|
|
|
Demecarium Bromide (100 mg)
|
|
|
Demeclocycline Hydrochloride (200 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Denatonium Benzoate (200 mg)
|
|
|
Deoxycholic Acid (Desoxycholic Acid) (100 mg)
|
|
|
Depramine (20 mg) (3-(5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride)
|
|
|
Dermatan Sulfate (25 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Desacetyl Diltiazem Hydrochloride (50 mg)
|
|
|
Desbenzyl Donepezil Hydrochloride (20 mg)
|
|
|
Desflurane (0.5 mL)
|
|
|
Desflurane Related Compound A (0.1 mL) (Bis-(1,2,2,2-tetrafluoroethyl)ether)
|
|
|
Desipramine Hydrochloride (125 mg)
|
|
|
Deslanoside (200 mg)
|
|
|
Desloratadine (200 mg)
|
|
|
Desloratadine Related Compound A (20 mg) (8-Bromo-6,11-dihydro-11-(piperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine)
|
|
|
Desloratadine Related Compound F (50 mg) (8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene) -5H-benzo[5,6]cyclohepta[1,2-b]pyridine)
|
|
|
Desloratadine Related Compound B (20 mg) (8-chloro-11-(1,2,3,6-tetrahydropyridin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine hydrochloride)
|
|
|
Desmethoxycurcumin (30 mg)
|
|
|
Desmopressin Acetate (1.75 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Desogestrel (100 mg)
|
|
|
Desogestrel Related Compound A (15 mg) (13-Ethyl-11-methylene-18,19-dinor-5alpha,17alpha-pregn-3-en-20-yn-17-ol)
|
|
|
Desogestrel Related Compound B (25 mg) (13-Ethyl-3-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol)
|
|
|
Desogestrel Related Compound C (25 mg) (13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol-3-one)
|
|
|
Desogestrel Related Compound D (25 mg) (13-Ethyl-11-methylenegon-4-en-17-one)
|
|
|
Desonide (250 mg)
|
|
|
Desonide Impurities Mixture (25 mg) (See long description for full chemical name)
|
|
|
Desoximetasone (200 mg)
|
|
|
Desoxycorticosterone Acetate (200 mg)
|
|
|
Desoxycorticosterone Pivalate (125 mg)
|
|
|
Desvenlafaxine (200 mg) (1-[2-(Dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol hydrogen)
|
|
|
Desvenlafaxine Fumarate (200 mg) (1-[2-(Dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol trans-butenedioate monohydrate)
|
|
|
Desvenlafaxine Succinate (200 mg) (1-[2-(Dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol hydrogen butanedioate monohydrate)
|
|
|
Desvenlafaxine Related Compound A (25 mg) (4-[1-(Cyclohex-1-en-1-yl)-2-(dimethylamino)ethyl]phenol)
|
|
|
Desvenlafaxine Related Compound B (25 mg) (4-[1-(1-Hydroxycyclohexyl)-2-(methylamino)ethyl]phenol)
|
|
|
Dexamethasone (125 mg)
|
|
|
Dexamethasone Acetate (200 mg)
|
|
|
Dexamethasone Phosphate (500 mg)
|
|
|
Dexamethasone Sodium Phosphate (500 mg)
|
|
|
Dexbrompheniramine Maleate (200 mg)
|
|
|
Dexchlorpheniramine Maleate (300 mg)
|
|
|
Dexketoprofen Tromethamine (200 mg)
|
|
|
Dexmedetomidine Hydrochloride (200 mg)
|
|
|
Dexpanthenol (500 mg)
|
|
|
Dextran 1 (50 mg)
|
|
|
Dextran T-10 (200 mg)
|
|
|
Dextran 40 (50 mg)
|
|
|
Dextran 40 System Suitability (200 mg) (PLANNED TO BE DISCONTINUED)
販売終了
|
|
|
Dextran 70 (50 mg)
|
|
|
デキストラン 70 System Suitability
販売終了
|
|
|
Dextran V0 Marker (100 mg)
|
|
|
Dextran 4 Calibration (100 mg)
|
|
|
Dextran 10 Calibration (100 mg)
|
|
|
Dextran 40 Calibration (100 mg)
|
|
|
Dextran 70 Calibration (100 mg)
|
|
|
Dextran 250 Calibration (100 mg)
|
|
|
Dextroamphetamine Related Compound A (25 mg) (1-Phenyl-2-propanol)
|
|
|
Dextrose (500 mg)
|
|
|
Diacetylated Monoglycerides (200 mg)
|
|
|
Diacetylfluorescein (200 mg)
|
|
|
Diatrizoic Acid (100 mg)
|
|
|
Diatrizoic Acid Related Compound A (50 mg) (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid)
|
|
|
Diaveridine (25 mg) (5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine)
|
|
|
Diazepam Related Compound A (25 mg) (2-methylamino-5-chlorobenzophenone)
|
|
|
Diazoxide (200 mg)
|
|
|
Dibucaine Hydrochloride (500 mg)
|
|
|
Dibutyl Phthalate (200 mg)
|
|
|
Dibutyl Sebacate (1 mL)
|
|
|
2,4-Dichlorophenol (100 mg)
|
|
|
Dichlorphenamide (200 mg)
|
|
|
Dichlorvos (150 mg) (2,2-dichlorovinyl dimethyl phosphate) (AS)
|
|
|
Diclazuril (200 mg)
|
|
|
Diclazuril System Suitability Mixture (50 mg)
|
|
|
Diclofenac Potassium (200 mg)
|
|
|
Diclofenac Sodium (200 mg)
|
|
|
Diclofenac Related Compound A (25 mg) (N-(2,6-dichlorophenyl)indolin-2-one)
|
|
|
ジクロキサシリンナトリウム
|
|
|
Dicyclomine Hydrochloride (125 mg)
|
|
|
Dicyclomine Related Compound A (40 mg) ([1,1'-Bi(cyclohexane)]-1-carboxylic acid)
|
|
|
Didanosine (200 mg)
|
|
|
Didanosine System Suitability Mixture (10 mg)
|
|
|
Didanosine Related Compound A (25 mg) (Hypoxanthine)
|
|
|
Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenosine)
|
|
|
Didymin (30 mg) ((RS)-5-Hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside)
|
|
|
Diethanolamine (3 x 1 mL)
|
|
|
Diethylcarbamazine Citrate (200 mg)
|
|
|
Diethylene Glycol (5 x 0.2 mL)
|
|
|
Diethylene Glycol Monoethyl Ether (4 x 0.25 mL/ampule)
|
|
|
Diethyl Phthalate (200 mg)
|
|
|
Diethylstilbestrol (200 mg)
|
|
|
ジエチルトルアミド(DEET)
|
|
|
Diethyltoluamide Related Compound A (25 mg) (N,N-Diethyl-4-toluamide)
|
|
|
Diflorasone Diacetate (200 mg)
|
|
|
Diflunisal (200 mg)
|
|
|
Digitalis (3 g)
|
|
|
Digitoxin (200 mg)
|
|
|
Diglycine (50 mg) (glycylglycine)
|
|
|
Digoxin (250 mg)
|
|
|
Dihydroartemisinin (200 mg) ((3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-Trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol)
|
|
|
Dihydrocapsaicin (25 mg)
|
|
|
Dihydrodaunorubicin Hydrochloride (20 mg) ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride)
|
|
|
17alpha-Dihydroequilin (50 mg) (Estra-1,3,5(10),7-tetraene-3,17alpha-diol)
|
|
|
Dihydroergotamine Mesylate (500 mg)
|
|
|
Dihydrostreptomycin Sulfate (200 mg)
|
|
|
ジヒドロタキステロール
販売終了
|
|
|
Dihydroxyacetone (250 mg)
|
|
|
Diloxanide Furoate (200 mg)
|
|
|
Diltiazem Hydrochloride (200 mg)
|
|
|
Diltiazem Related Compound A (AS) (25 mg) (trans-diltiazem hydrochloride)
|
|
|
Dimenhydrinate (200 mg)
|
|
|
Dimenhydrinate Related Compound E (15 mg) (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
|
|
|
Dimethyl Sulfoxide (3 g)
|
|
|
2,3-Dimethylaniline (50 mg)
|
|
|
6,6'-Dinicotinic Acid (50 mg)
|
|
|
Dinoprost Tromethamine (50 mg)
|
|
|
Dinoprostone (125 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid)
|
|
|
Diosmin (300 mg)
|
|
|
Diosmin for System Suitability (15 mg) (a mixture of acetoisovanillone, hesperidin, isorhoifolin, diosmin, linarin and diosmetin)
|
|
|
Dioxybenzone (150 mg)
|
|
|
Diphenhydramine Citrate (200 mg)
|
|
|
Diphenhydramine Hydrochloride (200 mg)
|
|
|
Diphenhydramine Related Compound B (20 mg) (3-(benzhydryloxy)propane-1,2-diol)
|
|
|
Diphenhydramine N-Oxide (25 mg) (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride)
|
|
|
Dipivefrin Related Compound E (25 mg) (4-[(Methylamino)acetyl]-1,2-phenylene dipivalate hydrochloride)
|
|
|
Dipyridamole (200 mg)
|
|
|
Dipyridamole Related Compound A (25 mg) (2,2'-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
|
|
|
Dipyridamole Related Compound B (25 mg) (2,2',2'',2''',2'''',2'''''-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol)
|
|
|
Dipyridamole Related Compound C (25 mg) (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
|
|
|
Dipyridamole Related Compound D (25 mg) (2,2'-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol)
|
|
|
Dipyridamole Related Compound E (25 mg) (2,2',2'',2'''-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol)
|
|
|
Dipyridamole Related Compound F (25 mg) (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
|
|
|
ジリスロマイシン (DISCONTINUED)
販売終了
|
|
|
Disodium Guanylate (350 mg)
|
|
|
Disodium Inosinate (500 mg)
|
|
|
Disodium 5'-Uridylate (500 mg)
|
|
|
Disopyramide Phosphate (200 mg)
|
|
|
Disulfiram (200 mg)
|
|
|
Divalproex Sodium (200 mg)
|
|
|
Dobutamine Hydrochloride (400 mg)
|
|
|
Docetaxel (200 mg) ((2R,3S)-N-Carboxy-3-phenylisoserine, N-tert-butyl ester, 13-ester with 5Beta,20-epoxy-1,2alpha,4,7Beta,10Beta,13alpha-hexahydroxytax-11-en-9-one 4-acetate 2-benzoate trihydrate)
|
|
|
Docetaxel Identification (50 mg)
|
|
|
Docetaxel System Suitability Mixture (15 mg)
|
|
|
Docosahexaenoic Acid Ethyl Ester (500 mg)
|
|
|
Docosyl Ferulate (50 mg)
|
|
|
Docusate Calcium (500 mg)
|
|
|
Docusate Sodium (1 g)
|
|
|
Docusate Sodium Related Compound B (40 mg) (disodium mono (2-ethylhexyl) sulfosuccinate)
|
|
|
Docusate Potassium (100 mg)
|
|
|
Dofetilide (200 mg)
|
|
|
Dofetilide Related Compound A (25 mg) (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
|
|
|
Dolasetron Mesylate (125 mg)
|
|
|
Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one, hydrochloride)
|
|
|
Donepezil-N-Oxide (20 mg)
|
|
|
Donepezil Hydrochloride (200 mg)
|
|
|
Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one)
|
|
|
Doxapram Hydrochloride (200 mg)
|
|
|
Doxapram Related Compound B (25 mg) (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one, hydrochloride)
|
|
|
Dopamine Hydrochloride (200 mg)
|
|
|
Dorzolamide Hydrochloride (200 mg)
|
|
|
Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride)
|
|
|
Dorzolamide Related Compound D (30 mg) ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride)
|
|
|
Dorzolamide Related Compound B (15 mg) ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride)
|
|
|
Doxazosin Mesylate (200 mg)
|
|
|
Doxazosin Related Compound A (20 mg) (N-1,4-Benzodioxane-2-carbonyl piperazine hydrochloride)
|
|
|
Doxazosin Related Compound B (20 mg) (6,7-dimethoxyquinazoline-2,4-dione)
|
|
|
Doxazosin Related Compound C (20 mg) (2-chloro-4-amino-6,7-dimethoxyquinazoline)
|
|
|
Doxazosin Related Compound D (20 mg) (1,4-benzodioxane-2-carboxylic acid)
|
|
|
Doxazosin Related Compound E (20 mg) (2,4-dichloro-6,7-dimethoxyquinazoline)
|
|
|
Doxazosin Related Compound F (15 mg) (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine)
|
|
|
Doxepin Hydrochloride (500 mg)
|
|
|
Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin-11(6H)-one)
|
|
|
Doxepin Related Compound B (50 mg) ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol)
|
|
|
Doxepin Related Compound C (25 mg) ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
|
|
|
Doxercalciferol (2 x 20 mg)
|
|
|
Doxorubicin Hydrochloride (50 mg)
|
|
|
Doxorubicinone (25 mg) ((8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione)
|
|
|
Doxycycline Monohydrate (100 mg)
|
|
|
Doxycycline Hyclate (200 mg)
|
|
|
Doxycycline Related Compound A (10 mg) ((4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, monohydrochloride)
|
|
|
Doxylamine Succinate (300 mg)
|
|
|
Drometrizole (25 mg) (2-(2H-Benzotriazol-2-yl)-p-cresol)
|
|
|
Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol)
販売終了
|
|
|
Drometrizole Trisiloxane Related Compound B (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol)
|
|
|
Drometrizole Trisiloxane Related Compound C (150 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol)
|
|
|
Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol)
販売終了
|
|
|
Drometrizole Trisiloxane Related Compound E (150 mg) (2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol)
|
|
|
Dronedarone Hydrochloride (125 mg)
|
|
|
Dronedarone Related Compound A (25 mg) (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride)
|
|
|
Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride)
|
|
|
Dronedarone Related Compound C (20 mg) ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone)
|
|
|
Dronedarone Related Compound D (20 mg) ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone)
|
|
|
Droperidol (250 mg)
|
|
|
Drospirenone (200 mg)
|
|
|
Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone)
|
|
|
Duloxetine Hydrochloride (100 mg)
|
|
|
Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
|
|
|
Duloxetine Related Compound H (30 mg) ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}-4-oxobutanoic acid) (COLD SHIPMENT REQUIRED)
|
|
|
Dutasteride (200 mg)
|
|
|
Dutasteride Resolution Mixture (20 mg)
|
|
|
Dyclonine Hydrochloride (200 mg)
|
|
|
Dyphylline (200 mg)
|
|
|
Diluted Isosorbide Mononitrate (750 mg)
|
|
|
Diluted Isosorbide Mononitrate Related Compound A (150 mg) (1,4:3,6-Dianhydro-D-glucitol 2-nitrate in lactose)
|
|
|
Diluted Nitroglycerin (200 mg/ampule; 5 ampules) (COLD SHIPMENT REQUIRED)
|
|
|
Dibasic Potassium Phosphate (500 mg)
|
|
|
D-Salicin (150 mg)
|
|
|
Defatted Powdered Soy (2.5 g)
|
|
|
D-Valacyclovir (25 mg) (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester)
|
|
|
D-Valganciclovir (10 mg) (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride)
|
|
